Join our community of 18,000+ people who've signed up to receive educational material. Learn more about RADICAVA ORS® (edaravone) — recognized by the FDA in 2024 for its major contribution to patient care due to oral route of administration, offering a less burdensome option vs IV administration. Updates in the series will educate you about:
FDA recognizes RADICAVA ORS® as MAJOR CONTRIBUTION TO PATIENT CARE Call a JourneyMate Resource Specialist at 1-855-457-6968.
FDA recognizes RADICAVA ORS® as MAJOR CONTRIBUTION TO PATIENT CARE Call a JourneyMate Resource Specialist at 1-855-457-6968.
Sign Up to Learn and Share
Keep informed with the RADICAVA® Educational Communications Series
How RADICAVA® May Help
Get patient-friendly information about the effectiveness and safety of RADICAVA® that's designed to be easy to understand.
Real RADICAVA Experiences
See what RADICAVA means to patients and caregivers as they share their personal experiences with treatment.
Financial Support Options
Learn more about a range of financial support options for eligible patients.
For eligibility requirements & terms and conditions for the Out-of-Pocket Assistance Program click here.
And Much More
You'll also receive additional ALS resources and support information when you sign up for the educational series.
Sign up now with the form below to begin receiving this informative educational series.
Have questions about RADICAVA® and ALS?
A JourneyMate Resource Specialist is ready to help you find information and educational resources about ALS, RADICAVA® as you move forward on your journey with ALS.
Call toll-free 1-855-457-6968 between 9 AM and 9 PM ET, Monday through Friday.